Invasive meningococcal disease cases already surpassing 2021 total figures

GSK Australia

Invasive Meningococcal Disease (IMD) cases are on the rise in Australia, as shown in the �Թ��վ Notifiable Diseases Surveillance System’s data, with the total number of cases to the end of September 2022 (86 cases) exceeding last year’s total (74 cases).¹

IMD is a rare bacterial infection, which can progress rapidly. Most people survive IMD, however, if it is not treated quickly, it may cause serious disability or loss of life within 24 hours.^2,3

Up to 1 in 10 people infected with IMD may die, and up to 1 in 5 survivors may develop serious long-term complications, including brain damage, deafness or loss of limbs.³

Babies (less than 2 years of age), and adolescents (15–19 years of age) are most vulnerable to the disease.⁴

Early signs and symptoms may be difficult to diagnose as they can easily be mistaken for a common cold, for example high fever or lethargy.²

/Public Release.

Women And Women’s Ministerial Council

CLP Government delivers improved access for Territory hunters

Government Acting Swiftly On Commonwealth Surcharges

Statement From NT Consumer Affairs And NT WorkSafe

Curtain Rises On New Era At Her Majesty’s Theatre Ballarat

Listening To Parents And Carers

What Is It With Liberals And Neo Nazis?

Labor limits SRL payments as $23 billion funding black hole remains

�Թ��վ